“…It is, however, unlikely that in RA, mast cells are activated through IgE-dependent pathways although rheumatoid factor belonging to IgE class of immunoglobulins has been described in a small subset of RA patients [23]. Rather, the synovial mast cells in RA are likely to be activated by complement components such as C5a and/or by immune complexes [24,8]. Unfortunately activation of mast cells by using these compounds would stimulate also other cell types in synovial tissue, macrophages and neutrophils in particular, besides the mast cells.…”